Equities

Ajooni Biotech Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
AJOONI:NSI

Ajooni Biotech Ltd

Actions
Consumer Staples Food Producers
  • Price (INR)5.00
  • Today's Change0.05 / 1.01%
  • Shares traded122.80k
  • 1 Year change-22.72%
  • Beta1.6281
Data delayed at least 15 minutes, as of Feb 16 2026 05:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Ajooni Biotech Limited is an animal health care solutions company. The Company is specialized in compounded animal feed and feed supplements. Its portfolio offers a wide range of quality cattle feed; cattle feed chips, camel feed, cotton oil cake, mustard oil cake and a wide range of feed supplements to cover the entire life cycle of an animal. The Company uses technologies for all its operations, such as Enterprise Resource Planning (ERP) software, programmable logic controller (PLC) system to control production process. It offers products for oral calclum, bloating, calclum gel, mastitis powder, mineral mixture, batisa powder, liver tonic, reproduction powder, utrine tonic, milk gainer, multi vitamin, growth promoter, foot and mouth disease (FMD) powder, cough syrup, egg growth promoter, and heat stock powder. Its feed supplements include CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, AUTOVITA and others. Its cattle feed products include Gold Magic plus, Silver Magic, 3 Star, among others.

  • Revenue in INR (TTM)1.51bn
  • Net income in INR49.05m
  • Incorporated2010
  • Employees109.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nirman Agri Genetics Ltd2.70bn284.14m503.81m38.001.770.40441.730.186435.4735.47337.42155.522.357.505.0371,131,750.0024.69--25.50--12.77--10.51--37.266,492.500.0027--273.43--143.03------
Agri-Tech (India) Ltd2.58m-9.30m801.48m2.00------311.26-1.55-1.550.4261--------1,287,500.00--1.40--1.60-31.92-82.37-361.32743.72--------16.11-14.04-111.42---54.03--
Ajooni Biotech Ltd1.51bn49.05m850.88m109.0015.680.934212.880.56340.3150.3159.655.291.465.306.92--4.743.635.394.5319.5713.753.262.052.009.210.1017--43.1623.4356.0257.607.73--
UMA Exports Ltd16.59bn-39.47m1.10bn38.00--0.569--0.0665-1.16-1.16493.3257.384.2915.3621.94436,589,800.00-1.035.27-2.0311.723.916.47-0.23921.160.92380.12450.48960.0012.5016.33-65.40-15.82213.15--
ShreeOswal Seeds and Chemicals Ltd2.18bn66.00k1.24bn31.00--2.59220.060.569-0.3719-0.371916.705.231.934.964.5370,214,420.000.00592.570.01456.814.755.360.0031.190.74230.93370.4936---8.5916.08184.812.99----
Data as of Feb 16 2026. Currency figures normalised to Ajooni Biotech Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.